Australia - inglese - Department of Health (Therapeutic Goods Administration)

universal pharmaceuticals pty ltd - evening primrose oil, quantity: 100 mg (equivalent: gamma-linolenic acid, qty 10 mg); natural fish oil, quantity: 180 mg (equivalent: eicosapentaenoic acid, qty 12.6 mg; equivalent: docosahexaenoic acid, qty 45 mg); d-alpha-tocopherol, quantity: 6.7 mg (equivalent: d-alpha-tocopherol, qty 10 iu); thyme oil, quantity: 1 mg - capsule, soft - excipient ingredients: gelatin; glycerol; soya oil - aids, assists or helps in the maintenance or improvement of general well-being. tuna oil is a valuable source of omega-3 polyunsaturated fatty acids eicosapentaenoic acid (epa) and docosahexaenoic acid (dha). these fatty acids assist mothers to-be meet the increased nutritional requirements of pregnancy. may also help support healthy eye function and assists in the relief of minor skin complaints. natural vitamin e is added to aid skin tissue repair and wound healing. for the treatment and prevention of vitamin e deficiency. evening primrose oil is a valuable source of the omega-6 fatty acid gamma-linolenic acid. this fatty acid may assist in maintaining healthy skin. dietary supplement.

Stati Uniti - inglese - NLM (National Library of Medicine)

mission pharmacal company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (p - ascorbic acid 120 mg - citranatal ® dha is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

alissa healthcare research ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Filippine - inglese - FDA (Food And Drug Administration)

amb hk enterprises, inc.; distributor: amb hk enterprises, inc. - eicosapentaenoic acid (epa) ethyl docosahexaenoic acid (dha) ethyl ester - softgel capsule - 465 mg/375 mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

strides pharma uk ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Stati Uniti - inglese - NLM (National Library of Medicine)

remedyrepack inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg per dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules and should continue this diet during treatment with omega-3-acid ethyl esters capsules. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceri

Stati Uniti - inglese - NLM (National Library of Medicine)

bryant ranch prepack - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - -  omega-3-acid ethyl esters is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). -  usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters. -  laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. -  limitations of use: -  the

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

imbat limited - omega-3-acid ethyl esters, eicosapentaenoic acid, docosahexanoic acid - capsules, soft - 1000 milligram - other lipid modifying agents

Australia - inglese - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

Australia - inglese - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated